Literature DB >> 30233734

MicroRNA-365 regulates the occurrence and immune response of sepsis following multiple trauma via interleukin-6.

Hui Gong1, Xiaomin Sheng1, Jianhua Xue1, Dongbo Zhu1.   

Abstract

In the present study, the expression of microRNA (miR)-365 and interleukin (IL)-6 in peripheral blood mononuclear cells and serum from patients with sepsis following multiple trauma has been investigated. A total of 26 patients with sepsis following multiple trauma were included as the experimental group, whereas 21 contemporaneous patients without sepsis following multiple trauma were included as the negative control group. The expression of IL-6 mRNA and miR-365 was determined by reverse transcription-quantitative polymerase chain reaction, and western blot analysis was used to measure IL-6 protein expression. ELISA was performed to determine the secretion of IL-6 protein. Following stimulation with lipopolysaccharide (LPS) for 24 h, THP-1 cells were used to examine the expression of miR-365 and the levels of IL-6 protein and mRNA in cells simulating sepsis. A dual luciferase reporter assay revealed that IL-6 mRNA was a direct target of miR-365. Patients with sepsis following multiple trauma exhibited significantly higher IL-6 mRNA and protein levels than patients without sepsis (P<0.05). In addition, miR-365 expression in patients with sepsis following trauma was significantly lower than in patients without sepsis (P<0.05). Similar effects were observed in THP-1 cells treated with LPS. The present study demonstrated that increased expression of IL-6 in patients with sepsis following multiple trauma is associated with decreased expression of miR-365. miR-365 may regulate the occurrence and immune response of sepsis following multiple trauma via IL-6. These results may elucidate agents for clinical diagnosis and treatment of the disease.

Entities:  

Keywords:  interleukin-6; microRNA-365; mononuclear cells; sepsis following multiple trauma

Year:  2018        PMID: 30233734      PMCID: PMC6143833          DOI: 10.3892/etm.2018.6647

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  33 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression.

Authors:  Niels C Riedemann; Thomas A Neff; Ren-Feng Guo; Kurt D Bernacki; Ines J Laudes; J Vidya Sarma; John D Lambris; Peter A Ward
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

3.  Strategies for the treatment of sepsis.

Authors:  H S Warren
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

Review 4.  lncRNAs and microRNAs with a role in cancer development.

Authors:  Julia Liz; Manel Esteller
Journal:  Biochim Biophys Acta       Date:  2015-07-04

Review 5.  Function and activation of NF-kappa B in the immune system.

Authors:  P A Baeuerle; T Henkel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

Review 6.  Interpreting Laboratory Tests in Infection: Making Sense of Biomarkers in Sepsis and Systemic Inflammatory Response Syndrome for Intensive Care Unit Patients.

Authors:  Jennifer B Martin; Jennifer E Badeaux
Journal:  Crit Care Nurs Clin North Am       Date:  2016-12-14       Impact factor: 1.326

7.  Systemic inflammatory response syndrome criteria in defining severe sepsis.

Authors:  Kirsi-Maija Kaukonen; Michael Bailey; David Pilcher; D Jamie Cooper; Rinaldo Bellomo
Journal:  N Engl J Med       Date:  2015-03-17       Impact factor: 91.245

Review 8.  Mucosal and enterocyte IL-6 production during sepsis and endotoxemia--role of transcription factors and regulation by the stress response.

Authors:  Timothy Pritts; Eric Hungness; Quan Wang; Bruce Robb; Dan Hershko; Per-Olof Hasselgren
Journal:  Am J Surg       Date:  2002-04       Impact factor: 2.565

9.  The impact of mild induced hypothermia on the rate of transfusion and the mortality in severely injured patients: a retrospective multi-centre study.

Authors:  Kai Oliver Jensen; Leonhard Held; Andrea Kraus; Frank Hildebrand; Philipp Mommsen; Ladislav Mica; Guido A Wanner; Peter Steiger; Rudolf M Moos; Hans-Peter Simmen; Kai Sprengel
Journal:  Eur J Med Res       Date:  2016-10-06       Impact factor: 2.175

10.  IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis.

Authors:  Amy E Anderson; Arthur G Pratt; Mamdouh A K Sedhom; John Paul Doran; Christine Routledge; Ben Hargreaves; Philip M Brown; Kim-Anh Lê Cao; John D Isaacs; Ranjeny Thomas
Journal:  Ann Rheum Dis       Date:  2015-02-03       Impact factor: 19.103

View more
  1 in total

1.  The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity for repurposing a clinically used oncological drug for the experimental therapy of sepsis.

Authors:  Akbar Ahmad; Juliana de Camargo Vieira; Aline Haas de Mello; Thais Martins de Lima; Suely Kubo Ariga; Denise Frediani Barbeiro; Hermes Vieira Barbeiro; Bartosz Szczesny; Gábor Törö; Nadiya Druzhyna; Elisa B Randi; Michela Marcatti; Tracy Toliver-Kinsky; András Kiss; Lucas Liaudet; Reinaldo Salomao; Francisco Garcia Soriano; Csaba Szabo
Journal:  Pharmacol Res       Date:  2019-05-06       Impact factor: 7.658

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.